Back

Chairperson conclusion & Closing question

18 March 2018 (14:40 - 14:45)
Organised by:
Congress Presentation Part of: Tough decisions in anticoagulation in atrial fibrillation Stroke Prevention in Cardioversion EHRA Premium Access EHRA 2018

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO
Doctor S. Themistoclakis (Venice, IT)
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO
Video
Presentation thumbnail
Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON
Video

Access the full session

Session thumbnail
Tough decisions in anticoagulation in atrial fibrillation

The Event

Event poster

EHRA 2018

18 March 2018 14:40 CET
You may be interested in
thumbnail
Congress Presentation
Closing remarks
27 April 2024
thumbnail
Congress Session
Closing Ceremony
24 June 2023
thumbnail
Congress Presentation
Conclusions
31 March 2025
thumbnail
Congress Presentation
Questions & answers.
4 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources